BBP BioShares Biotechnology Products ETF

Seeks to track, before fees and expenses, the LifeSci Biotechnology Products Index. The Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval.

$46.14  -1.64 (-3.43%)
As of 12/03/2021 16:00:00 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     Virtus ETF Solutions
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  12/16/2014
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.17%
Market cap:  $21,499,436
Average volume:  2,963
Fees:     0.7900%

---

Index Information

---

LifeSci Biotechnology Products Index
Index symbol:  LSCIBP
Provider:   LifeSci Index Partners
Index weighting:   Equal weighted
Index inception date:  11/03/2014
Backtesting data exists:   Yes
Strategy:  Equal weighting